Vol 2025, No 9 (2025)

Aug

Table of Contents

Research & Development

Novartis Signs US$2.2 B Deal with Arrowhead Pharmaceuticals for RNAi Therapy Abstract pdf html
Lucy Haggerty

Mergers & Acquisitions

AbbVie to Acquire Gilgamesh’s Psychedelic Depression Treatment for US$1.2 B Abstract pdf html
Lucy Haggerty

Opinion & Analysis

IQVIA Pharma Deals Half-Year Review of 2025 Abstract pdf
Lucy Haggerty,Taskin Ahmed, Ayush Saxena & Shikha Kashyap


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.